Value through Innovation27 July 2016

Clinical Study Results

  • Diclofenac + Capsaicin - Pain
    Clinical Study Number 1358.1
    Study Indication Pain
    Product Diclofenac + Capsaicin
    Generic Name Diclofenac + Capsaicin
    Lab Code
    Clinical Phase III
    Study Title

    A randomised, controlled multi-centre parallel group study to assess the efficacy and safety of multiple doses of a topically applied combination containing diclofenac 2% + capsaicin 0.075% (2 g formulation per application; 2-times daily for 5 days) compared to placebo, as well as to diclofenac 2% and capsaicin 0.075% in patients with acute back or neck pain

    Study Document Trial synopsis 1358.1 english
  • Diclofenac + Capsaicin - Pain
    Clinical Study Number 1358.2
    Study Indication Pain
    Product Diclofenac + Capsaicin
    Generic Name Diclofenac + Capsaicin
    Lab Code
    Clinical Phase I
    Study Title

    A Single Center, Multiple-Dose, Open-Label, Randomized, Three-Period Crossover Study To Determine The Relative Bioavailability Of Diclofenac In The Topical Gel Combination Product (Diclofenac 2% + Capsaicin 0.075%) Compared To Diclofenac Mono Gel 2% And Voltarol® 12 Hour Emulgel 2.32% Gel In At Least 42 Healthy Males And Females

    Study Document Trial synopsis 1358.2 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.